MYCN and neoplasm: Unfortunately, in the data sets analyzed stage 4S NB patients with tumor MYCN amplified are only 9 (4 in Kocak-649, 1 in Oberthuer-251, and 4 in SEQC-RPM database respectively), thus preventing survival analysis from being performed.